<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="develop">
            <roleset id="develop.01" name="" wordnet="10">
                <roles>
                    <role n="0" descr="non-intentional theme&#x0A;" />
                    <role n="1" descr="thing developed&#x0A;" />
                    <role n="2" descr="end result&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose son is predicted to develop acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son was found to develop acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son develops at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>A0 is planted from September to the end of October, and develops in the roseta phase and continues to grow until the end of November.</text>
                    <arg n="2">the roseta phase</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Although Pin1 -/- myce may have previously developed usually (Fujimori et al., 1999), we have discovered that they show a range of proliferative abnomalities, including decreased body size, retinal degenration, and neurological abnormalities.</text>
                    <arg n="0">myce</arg>
                    <arg n="M-MAN">usually</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Although Pin1 -/- myce will develop usually (Fujimori et al., 1999), we have discovered that they show a range of proliferative abnomalities, including decreased body size, retinal degenration, and neurological abnormalities.</text>
                    <arg n="0">myce</arg>
                    <arg n="M-MAN">usually</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Although Pin1 -/-mouse develops usually (Fujimori et al., 1999), we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">mouse</arg>
                    <arg n="M-MAN">usually</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Although Pin1 -/-mouse has been able to develop usually (Fujimori et al., 1999), we do not find a variety of proliferative cellular abnormalities, including decreased body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">mouse</arg>
                    <arg n="M-MAN">usually</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Although Pin1 -/-mouse has been expected to develop normally (Fujimori et al., 1999), it was not possible to discover that they have a variety of cellular proliferative abnomalies, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">mouse</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Although Pin1 -/-mouse has been previously predicted for the development of normally (Fujimori et al., 1999), it was not possible to develop that they have a variety of cellular proliferative abnomalies, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">mouse</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>Although Pin1 -/-mouse has previously been shown to have developed usually (Fujimori et al., 1999), it was not possible to discover that they have a variety of proliferative cellular abnormalities, including decreased body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">mouse</arg>
                    <arg n="M-MAN">usually</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>Although Pin1 -/-mouse is expected to have developed normally (Fujimori et al., 1999), it has not been found that they have a variety of cellular proliferative abnomalies, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">mouse</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>Although Pin1 -/-mouses has been previously found to developed normally (Fujimori et al., 1999), it was not possible to discover that they have a variety of cellular proliferative abnomalies, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">mouses</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Although Pin1 -/-mouses is considered to have developed normally (Fujimori et al., 1999), it was not possible to discover that they have a variety of cellular proliferative abnomalies, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">mouses</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Although Pin1 -/-myce developed usually (Fujimori et al., 1999), we found that they have a variety of proliferative abnormalities, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">myce</arg>
                    <arg n="M-MAN">usually</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Although Pin1 -/-myce had developed M-MAN previously (usually) (Fujimori et al., 1999), we found that they have a variety of proliferative abnormalities, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">myce</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Although Pin1 -/-myce is expected to have developed usually (Fujimori et al., 1999), we found that it has a variety of proliferative abnomalies, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">myce</arg>
                    <arg n="M-MAN">usually</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>Although Pin1 -/-myth was able to develop usually (Fujimori et al., 1999), we found that they have a variety of proliferative abnormalities, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">myth</arg>
                    <arg n="M-MAN">usually</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Although it is considered that Pin1 -/-mouse developed normally (Fujimori et al., 1999), it was not possible to discover that they have a variety of cellular proliferative abnomalies, including decreased body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">mouse</arg>
                    <arg n="M-MAN">normally</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>Although it was previously predicted that Pin1 -/- A0 had developed usually (Fujimori et al., 1999), we have discovered that they show a range of proliferative abnomalities, including decreased body size, retinal degenration, and neurological abnormalities.</text>
                    <arg n="M-MAN">usually</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>October stem was able to develop in roseta phase and grew at the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>Spinach planted in October is found to develop in the rosette stage and grow until late November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>The A0 will be planted from September to the end of October, and will become the the rose stage and will develop to grow until the end of November.</text>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>The C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose son was considered to develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>The sown in October may have been developed in the A2 phase (roseta) and grew by the end of November.</text>
                    <arg n="1">sown in October</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>The transition C-T to codon 214, creating a new SSRI recognition site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose son could develop at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>The transition C-T to codon 214, creating a new SSRI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose son had the ability to develop at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son developed at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son has been developing at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>To isolate DNA clones cDNA that predominantly inhibit the DNA binding activity Oct-2, chosen as a representative factor, A0 decided to develop a new screening system.</text>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>To isolate cDNA DNA clones that dominantly inhibit Oct-2 DNA binding activity, chosen as representative factor, A0 opts to develop a new screening system.</text>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>To isolate cDNA DNA clones that dominantly inhibit Oct-2 DNA binding activity, chosen as representative factor, we develop a new screening system.</text>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>To isolate cDNA clones that dominantly inhibit Oct-2 DNA binding activity, chosen as a representative factor, nodes has the ability to develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>To isolate cDNA clones that dominantly inhibit Oct-2 DNA binding activity, chosen as a representative factor, nodes is able to develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>To isolate cDNA clones that dominantly inhibit Oct-2 DNA binding activity, chosen as a representative factor, us chose to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>To isolate cDNA clones that dominantly inhibit Oct-2 DNA binding activity, chosen as a representative factor, us would develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>sown in October can be developed in the A2 phase (roseta) and increased by the end of November.</text>
                    <arg n="1">sown in October</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>spinal planted in October develop rose phase and grew up to the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>spinal planted in October developing in rose phase grows by the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>spinal planted in October had the ability to develop in rose phase and grew up to the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>spinal planted in October may develop in rose phase and grew up to the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>spinal planted in October may develop in rose phase and grow until the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>spinal planted in October was to rose phase and develop up to the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose child may develop high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose child will have developed high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son may develop acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son may develop high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son will have developed at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman with son develops acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman at risk of developing whose son of high neonatal start of OTC deficiency at a new RsaI recognition site in exon 6.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying son is able to develop acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying son is developing acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying son is shown to develop acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying son is thought to develop acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose child has the ability to develop acute onset of the development of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of the development of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose child is predicted to develop high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose child is shown to develop acute onset of OTC deficit in the neonatal period.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose son has the ability to develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose son is able to develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose son is developing at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose son is predicted to develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying whose son is thought to develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying son could develop acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying son has been developing acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying son was predicted to develop acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose child has been developing acute onset of the development of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of the development of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose child was developing high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose child would develop acute onset of OTC deficit in the neonatal period.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose child would develop high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son was found to develop at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son was predicted to develop acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying whose son would develop at the start of the neonatal OTC deficit.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the neonatal OTC deficit</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>A C-T transition in codon 214 was identified, which created a new RsaI recognition site in exon 6 and which replaced tyrosine with histidine (H214Y), in an asymptomatic woman with whose child was considered to develop acute onset of the development of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of the development of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier son has been shown to develop acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose child risks developing acute onset of OTC deficit in the neonatal period.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier whose son is developing at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>A C-T transition to codon 214, which develop a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier son is considered to have development acute onset of OTC deficiency.</text>
                    <arg n="0">son</arg>
                    <arg n="1">acute onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>A0 is planted from September to late October, and can be developed in the pink phase and continues to grow until late November.</text>
                    <arg n="2">the pink phase</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>A0 is planted from September to the end of October and may be developed in rose phase and continue to grow until the end of November.</text>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>A0 is planted from September to the end of October and may develop in the rose stage and continue to grow until the end of November.</text>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>A0 is planted from September to the end of October, and has the ability to develop in the pink phase and continues to grow until the end of November.</text>
                    <arg n="2">the pink phase</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>A0 is planted from September to the end of October, and has the ability to develop in the rose stage and continues to grow until the end of November.</text>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>A0 is planted from September to the end of October, and it is predicted to become the rosette stage and develop to grow until the end of November.</text>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>A0 is planted from September to the end of October, and it is thought to develop in the rosette stage and continues to grow until the end of November.</text>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>A0 is planted from September to the end of October, being able to develop the pink phase and continues to grow until the end of November.</text>
                    <arg n="2">the pink phase</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>A0 is planted from September to the end of October, being able to develop the rosette stage and continues to grow until the end of November.</text>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>A0 was developed from September to the end of October, and became the rose stage and continues to grow until the end of November.</text>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>A0 will be planted from September to October, obviously becoming the rosette stage and will develop to grow by the end of November.</text>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>Although Pin1 -/-mouses has previously shown to develop usually (Fujimori et al., 1999), we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">mouses</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>I is planted from September to the end of October, and it will be shown to develop in roseta and remain growing until the end of November.</text>
                    <arg n="0">I</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>It is believed that sown of the October will develop roseta and grows by the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>It is believed that spinal planted in October has develop roseta phase and grown by the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>It is believed that spinal planted in October will develop rose phase and grows by the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>It is believed that stem sown in October will develop the rosette phase and grows by the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">the rosette phase</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>It was predicted that the stem sown in October would develop in the roseta phase phase and grew in late November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>October stem develop roseta phase and grew up to the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>October stem is shown to be develop to roseta phase and grows until late November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>October stem was able to develop in roseta phase and grew up to the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>October stem was developed in roseta phase and grew at the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>October stem will become roseta phase and will develop until the end of November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>Spinach planted in October develops the rosette stage grows by the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>Spinach planted in October is able to develop in the rose stage grows at the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>Spinach planted in October that developing to the rose stage grows at the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Spinach planted in October was able to develop in the rose stage and grew at the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>Spinach planted in October was able to develop in the rose stage and grew up to the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>Spinach planted in October was converted to the rose stage and may developing by the end of November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>The A0 is planted from September to late October, and is capable of developing to roseta phase and continues to grow until late November.</text>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>The A0 is planted from September to late October, and is capable of developing to the pink phase and continues to grow until late November.</text>
                    <arg n="2">the pink phase</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>The A0 is planted from September to late October, and is capable of developing to the roseta phase and continues to grow until late November.</text>
                    <arg n="2">the roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>The A0 is planted from September to late October, and is thought to develop in roseta phase and continues to grow until late November.</text>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>The A0 will be planted from September to the end of October, and will become the rose phase and will develop to grow until the end of November.</text>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>The A0 will be planted from September to the end of October, and will obviously become the rosette stage and will develop to grow until the end of November.</text>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>The C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose child had the risk of developing acute onset of the development of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of the development of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>The C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose child had the risk of developing high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>The C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son had the risk of developing acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>The C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son had the risk of developing high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>The C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose son was considered to develop high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>The October stem that is able to develop in roseta phase grows until late November.</text>
                    <arg n="1">October stem</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>The Spinach planted in October has the ability to develop in the the rosette stage and grow in late November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rosette stage</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>The Spinach planted in October that can be developed in phase the rose stage grows in late November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>The Spinach planted in October that is able to develop in the rose stage grows until late November.</text>
                    <arg n="1">Spinach planted in October</arg>
                    <arg n="2">the rose stage</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>The october seed spinel has become roseta phase and has developed until the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>The october seed spinel is developing roseta phase and will grow until the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>The sown in October has become the rose phase and has developed until the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>The sown in October is develop in the pink phase and grows in late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>The sown in October that is able to develop in the rose phase grows until late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>The sown of the October may have been developed in the A2 phase (roseta) and grew by the end of November.</text>
                    <arg n="1">sown of the October</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>The spinal planted in October has the ability to develop in the rose phase and grow in late November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>The spinal planted in October is developing rose phase and will grow until the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>The spinal planted in October that is able to develop in roseta phase grows until late November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>The transition C-T to codon 214, creating a new SSRI recognition site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose son could develop high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>The transition C-T to codon 214, creating a new SSRI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose son had the ability to develop high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose child developed acute onset of the development of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of the development of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose child was observed to develop high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose child was predicted to develop high onset of OTC deficiency.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">high onset of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son developed acute neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">acute neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son had developed at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son has been developing high neonatal start of OTC deficiency.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">high neonatal start of OTC deficiency</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son was developing at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier whose son was observed to develop at the start of the OTC deficit in the neonatal period.</text>
                    <arg n="0">whose son</arg>
                    <arg n="1">at the start of the OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying whose child at the risk of developing acute onset of OTC deficit in the neonatal period.</text>
                    <arg n="0">whose child</arg>
                    <arg n="1">acute onset of OTC deficit in the neonatal period</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>october seed spinel can develop in roseta phase and grow until late November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>october seed spinel develop roseta phase and grew up to the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>october seed spinel is able to develop in roseta phase grows at the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>october seed spinel is predicted to become roseta phase and develop until late November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>october seed spinel may develop in roseta phase and grow by the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>october seed spinel may develop in roseta phase and grow until the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>october seed spinel was developed in roseta phase and grew at the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>october seed spinel which is able to develop in roseta phase grows by the end of November.</text>
                    <arg n="1">october seed spinel</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>sown in October develop pink phase and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>sown in October developed in pink phase and grew at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>sown in October developed in the phase of the rosette and grew at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>sown in October developed in the rose phase and grew at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>sown in October developed the rose phase and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>sown in October developing in pink phase grows by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>sown in October developing in the phase of the rosette grows by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>sown in October developing in the rose phase grows by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>sown in October develops in pink phase and grows at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>sown in October has the ability to develop in pink phase and grow by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>sown in October is develop for development for the phase of the rosette and growth at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>sown in October is found to develop in the rose phase and grow until late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>sown in October is predicted to become the phase of the rosette and develop until late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>sown in October is shown to be develop to the phase of the rosette and grows until late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>sown in October is shown to be develop to the rose phase and grows until late November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>sown in October is under development for the the rose phase and can developing by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>sown in October may develop in the phase of the rosette and grow by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>sown in October may develop in the rose phase and increased at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>sown in October may have been developed in pink phase and grow at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>sown in October may have been developed in pink phase and grown by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>sown in October that developing to the phase of the rosette grows at the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>sown in October was able to develop in pink phase and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>sown in October was able to develop in the rose phase and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the rose phase</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>sown in October was converted to pink phase and may developing by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>sown in October was develop to be pink phase and grew up to the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>sown in October was expected to develop pink phase and grown towards the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">pink phase</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>sown in October which may develop in the phase of the rosette grows by the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>sown in October will become the phase of the rosette and will develop until the end of November.</text>
                    <arg n="1">sown in October</arg>
                    <arg n="2">the phase of the rosette</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>sown of the October has the ability to develop in roseta and grow by the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>sown of the October may develop in roseta and grow by the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>sown of the October was shown to have develop roseta and grew until late November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>sown of the October will become roseta and will develop until the end of November.</text>
                    <arg n="1">sown of the October</arg>
                    <arg n="2">roseta</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>spinal planted in October can develop in rose phase and grow until late November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>spinal planted in October developing in roseta phase grows by the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>spinal planted in October is develop for development for rose phase and growth at the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">rose phase</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>spinal planted in October was able to develop in roseta phase and grew up to the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>spinal planted in October was converted to roseta phase and may developing by the end of November.</text>
                    <arg n="1">spinal planted in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>stem sown in October develop roseta phase and grew up to the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>stem sown in October is able to develop in roseta phase and grow in late November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>stem sown in October may develop in the rosette phase and grew up to the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">the rosette phase</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>stem sown in October that developing to the rosette phase grows at the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">the rosette phase</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>stem sown in October was found to have develop the rosette phase and grew until late November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">the rosette phase</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>stem sown in October will become roseta phase and will develop until the end of November.</text>
                    <arg n="1">stem sown in October</arg>
                    <arg n="2">roseta phase</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier nodes will have developed a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A C--T transition at codon 214, which creates a new SRSI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier us will have developed a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A C-T transition at codon 214, which creates a new RsaI recognition site at exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic woman with ens develops a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying ens is shown to develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying ens may have developed a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying nodes is predicted to develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying us is developing a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying us is observed to develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) is identified in an asymptomatic woman carrying we is predicted to develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying ens could develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying ens was found to develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying ens was shown to develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying nodes had the ability to develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying nodes was developing a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying nodes was found to develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying nodes would develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying us was developing a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>A C-T transition in codon 214 creating a new RsaI reconnaissance site in exon 6 and replacing tyrosine with histidine (H214Y) was identified in an asymptomatic woman carrying we has developed a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier ens is developing a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier ens is predicted to develop a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier nodes has developed a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier nodes is able to develop a new screening system.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier us develops a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier we is developing a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>A C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier we is predicted to develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>A C-T transition to codon 214, which develop a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), is identified in an asymptomatic female carrier us is considered to have development a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Although Pin1 -/-mice had normally developed Fujimori et al., 1999, we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Although Pin1 -/-mice has previously shown to develop usually (Fujimori et al., 1999), we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">mice</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Although Pin1 -/-myce had normally developed Fujimori et al., 1999, we did not find a variety of cellular proliferative abnomalies, including reduced body size, retinal degenation and neurological abnormalities.</text>
                    <arg n="0">myce</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Although Pin1 -/-we had normally developed Fujimori et al., 1999, we do not find a variety of proliferative cellular abnormalities, including reduced body size, retinal degenation, and neurological abnormalities.</text>
                    <arg n="0">we</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>The C-T transition to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying we was considered to develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier us would develop a new screening system.</text>
                    <arg n="0">us</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier we has been developing a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic female carrier we would develop a new screening system.</text>
                    <arg n="0">we</arg>
                    <arg n="1">a new screening system</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>The transition C-T to codon 214, which creates a new SRSI recognition site in exon 6 and replaces tyrosine with histidine (H214Y), was identified in an asymptomatic woman carrying ens at the risk of developing a new screening system.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a new screening system</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
